After participating
in this activity, participants should be able to:
Discuss the
prevalence and causes of osteoporosis in ESRD;
 Summarize the skeletal effects of parathyroid hormone in uremia;
Describe the non-skeletal effects of parathyroid hormone and how these might be related to uremia;
Understand the differences between currently used vitamin D analogs used to treat hyperparathyroidism in ESRD patients.
Kevin J. Martin, MB, BCh
Professor of Internal Medicine
Director, Division of Nephrology
Saint Louis University, St. Louis, MO
Sharon M. Moe, MD
Associate Professor of Medicine
Indiana University and Roudebush VAMC
Indianapolis, IN
Eduardo
Slatopolsky, MD
Professor of Medicine
Washington University School of Medicine
St. Louis, MO
|
|
 |
|
|
Post-test and evaluation form are at
this link, but you must listen to all talks
from this symposium prior to completing the
test.
|
|
CME: Access Medical Group, Ltd. is accredited by the Accreditation
Council for Continuing Medical Education (AACME) to sponsor continuing medical education
for physicians. Access Medical Group, Ltd.
designates this educational
activity for up to 2.0 hours in category 1 credit
towards the AMA Physician's Recognition Award. Each physician
should claim only those hours of credit actually spent
in the educational activity.
CEU: These talks are also designated to provide 2.0 hours of CEU Nursing Education credits, sponsored
by the Renal Education Association. The Renal Education Association is accredited by
the State of California Board of Nursing to provide continuing education for nurses
(Provider number: CEP 13092).
Posting date: March 1, 2002.
Review date: March 1, 2003 |
|
INSTRUCTIONS FOR CREDIT : |
Participation
in this self-study activity should be completed in approximately
two (2.0) hours. There are no fees for participating and receiving
CME or CEU credit for this activity. To successfully complete this
activity and receive credit, participants must follow these
steps during the period March 1, 2002 through March 1, 2003.
1. Register for continuing education credit by completing the
registration process.
2. Read the goals and learning objectives.
3. Read the article text and tables, and review figures.
4. Read, complete, and submit answers to the post test questions
and evaluation questions. You must receive a test score of at
least 75% and respond to all evaluation questions to receive
your online CME or CEU certificate.
The
primary target audience is physicians involved in the care of renal patients (CME), and nephrology nurses, dietitians,
dialysis technicians and pharmacists (CEU).
|
FACULTY
DISCLOSURE STATEMENTS : |
All
faculty participating in continuing medical education programs
are expected to disclose to the program audience any real or
apparent conflict of interest related to the subject under discussion.
The faculty disclosure information is as follows:
Martin, Kevin: Grants: Abbott, Amgen. Consultantships: Abbott, Amgen. Honoraria: Abbott.
Moe, Sharon: Grants or research support: Amgen. Consultantships: Genzyme, Amgen, Bone Care International, Abbott; stocks: Lilly; honoraria: Genzyme, Amgen, Bone Care International,
Abbott
Slatopolsky, Eduardo:
Grant support: Abbott, Geltey. Consutantships: Genzyme.
Stocks: Merck, Pfizer, Amgen. Honoraria: Abbott, Genzyme. Funding: Various
pharmaceutical companies.
|
DISCLOSURE OF UNLABELED USE: |
This
educational activity may contain discussion of published and/or
investigational uses of agents that are not indicated by FDA.
Access Medical Group, Ltd., ASN, HDCN and the Renal Education Association do not recommend the
use of any agent outside of the labeled indications. Please
refer to the official prescribing information for each product
for discussion of approved indications, contraindications and
warnings.
|
|
